Add to Calendar 8/26/2020 8:00:00 AM 8/27/2020 5:00:00 PM 2020 State of Possible Conference

Special thanks to our Platinum Sponsor Morgan Stanley

Registered attendees will receive an email with the subject line “Welcome to the State of Possible Conference 2020 - Event Access Link” from

The State of Possible Conference, MassBio's Annual Meeting, will now be hosted virtually on August 26-27, 2020. Featuring interactive networking and a groundbreaking viewer experience, this event will not be your average webinar.  

We will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks®, inspiring and engaging content in the style of a TED Talk.

"It's the Woodstock of Life Sciences, with all-star performers playing their greatest hits all on one stage.” – 2019 State of Possible Conference attendee
If you haven’t attended our State of Possible Conference before, it is the premier east coast life sciences conference. We have some of the brightest names in biotech talking about the issues impacting our industry, covering topics from the realities of precision medicine to advancing new drug targets faster.

To inquire about sponsorship opportunities, contact Laura Rudberg.

2020 State of Possible Conference Refund Policy

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
Online Conference, Link will be sent in advance of the event.
Head of Operations & Commercialization, Astellas Institute for Regenerative Medicine (AIRM)
Richard Cassidy is the Head of Operations & Commercialization at the Astellas Institute for Regenerative Medicine (AIRM), based outside Boston. He is responsible for building Astellas’ commercialization approach for its cell-based therapy portfolio, a new and exciting area with the potential to transform healthcare for patients. He also leads Facilities, EH&S and Communications for AIRM. An engineer by training, Richard is driven by a desire to improve and refine how pharmaceuticals contribute to healthcare through changing the companies that create and deliver those pharmaceuticals. He benefits from several years of experience as a cross-functional change agent at both regional and global levels and led the process to develop and execute Astellas’ most recent global corporate strategic plan. Across more than 20 years, he has worked in Pharma, Diagnostics, Med Tech and at a software start-up, giving him a unique and useful perspective as all of these areas rapidly converge. When he’s not working, Richard enjoys exploring the great outdoors with his family, whether hiking in the summer or skiing in the winter.

Brought to you by